The contribution of medial calcification to vascular dysfunction in renal failure is unknown. 22
Introduction 37 38
The incidence of cardiovascular disease is markedly increased in patients with advanced 39 kidney disease and is associated with changes in vascular function. Arterial compliance is 40 decreased (16) and correlates strongly with death (3) . Endothelial function is also abnormal, 41 manifest primarily as reduced endothelium-dependent vasodilatation (9; 10; 12; 20; 21) and may 42 contribute to hypertension and ischemia. Renal failure may affect the function of vascular 43 smooth muscle as well but the data are disparate with some studies showing enhanced 44 responsiveness and other showing reduced responsiveness to alpha adrenergic stimulation (2; 7; 45 19; 27; 32). 46
The etiology of vascular dysfunction in renal failure is not known. Histologic studies 47
have shown changes in the medial layer of arteries consisting of both hypertrophy and 48 hyperplasia of smooth muscle cells as well as increased matrix (1), which could explain the 49 decrease in compliance. There is also a high incidence of atherosclerosis (8), which might also 50 lower compliance and is associated with endothelial dysfunction. Increased oxidant stress in 51 renal failure (6) is another potential cause of endothelial dysfunction. 52
Smooth muscle calcification is another common arterial lesion in advanced kidney 53 disease that could also contribute to vascular dysfunction. Although it has been considered to be 54 benign, recent data have shown that vascular calcification correlates with cardiovascular events 55 and death (15). This may be related to a decrease in arterial compliance since increased pulse 56 wave velocity correlates with vascular calcification and cardiovascular disease in advanced 57 kidney disease (4; 26). However, pulse-wave velocity can be influenced by smooth muscle tone 58 in addition to elasticity (18) and interpretation of these studies is also complicated by the fact 59 that they cannot distinguish between the medial calcification (Monckeberg's sclerosis) 60 commonly associated with renal failure and the intimal (atherosclerotic) calcification that 61 frequently coexists. Thus, medial calcification in uremia has not been directly correlated with 62 arterial compliance and its effect on endothelial or smooth muscle function is also unclear. 63
To address the effects of medial vascular calcification in uremia on vascular function, we 64 performed ex vivo measurements of compliance, contraction, and relaxation in calcified and 65 noncalcified aortas from uremic rats and in control aortas from nonuremic rats. Uremia and 66 dehydrogenase (ThermoDMA, Arlington, TX Smooth muscle contractile function was investigated by measuring force generation in 158 response to depolarization (using KCl) and to the α-adrenoceptor agonist phenylephrine (PE). 159
Sensitivity to KCl was increased in uremic aortas (Fig 2) , with no difference between 160 noncalcified and calcified aortas (EC 50 28.1 + 1.0, 18.0 + 1.7, 17.5 + 2.8 nM in control, uremic 161 noncalcified, and uremic calcified respectively; p < 0.01 vs. control for either noncalcified or 162 calcified uremic aortas). In addition, the maximum force per cross-sectional area obtained with 163
KCl was markedly decreased in uremic aortas, again with no difference between noncalcified 164 and calcified aortas (2.38 + 0.33, 0.87 + 0.14, and 1.01 + 0.43 mN/mm 2 in control, uremic 165 noncalcified, and uremic calcified respectively; p < 0.05 vs. control; n = 6-8). In the case of 166 phenylephrine (PE) there were no changes in sensitivity ( uncertain. This study indicates that at least some of the reduced arterial compliance in CKD and 213 ESRD can be explained by medial calcification. This is consistent with the correlation between 214 PWV and medial calcification in nonuremic rats treated with nicotine and toxic doses of vitamin 215 D (22) and with the increased pulse wave velocity in uremic rats treated with doses of 216 doxercalciferol that produce aortic calcification (23) . 217
A recent study in uremic ApoE-/-and wild-type mice, in which most of the aortic 218 calcification was intimal, found no correlation between pulse-wave velocity and aortic 219 calcification (17). This finding and the decreased compliance observed in the current study, 220 suggest that only medial calcification reduces arterial compliance, which may be related to the 221 loss of elastin in medial calcification (22). Pulse-wave velocity was increased in the uremic mice 222 in the absence of calcification or other structural changes in the aorta, demonstrating that PWV is 223 not necessarily indicative of changes in arterial structure. In the current study, compliance was 224 not altered in uremic aortas that were not calcified, possibly due to different hemodynamics, 225 different species, or the shorter duration of uremia. 226
Although marked changes in smooth muscle and endothelial function were observed in 227 calcified vessels, the changes were qualitatively and quantitatively the same in noncalcified 228 uremic vessels, indicating that the effects on vascular function were the result of uremia rather 229 than calcification. It is possible that intimal calcification, which did not occur in this study, can 230 alter vascular function. A severe reduction in maximal force generation in calcified aortas was 231 also noted in a previous study of rats made uremic by 5/6 nephrectomy and given a very high 232 calcium diet and high doses of calcitriol (29). The calcification was exclusively medial and 233 histologically identical to that obtained in adenine-fed rats in this study. Both calcification and 234 force generation were improved in rats treated with etidronate, suggesting that medial 235 calcification affects smooth muscle function. However, noncalcified uremic aortas were not 236 studied and calcium content was not measured or correlated with force generation. In another 237 study, treatment of uremic rats with paricalcitol increased aortic calcification and reduced force 238 generation in superior mesenteric arteries (11) but it is not clear whether these vessels were 239 calcified. Vasodilatation of these arteries was not altered by paricalcitol, consistent with the 240 present results showing no effect of medial calcification on relaxation. 241
The lack of effect of medial calcification on vascular function despite extensive and 242 grossly visible calcification with reduced compliance may be explained by the fact that 243 contraction and relaxation were measured under isometric conditions in which very little wall 244 motion is necessary to measure force. It is also possible that the profound effects of uremia 245 alone on contraction and relaxation masked any additional effect of calcification. Changes in 246 vessel function might therefore be more apparent when medial calcification occurs in the 247 absence of renal failure, such as in diabetes and aging. Hemodynamics are also determined by 248 chronic changes in vessel caliber related to remodeling of smooth muscle, and this could be 249 altered by medial calcification in the absence of changes in acute vasomotor responses. 250
This study demonstrated marked alterations in both smooth muscle and endothelial 251 function in uremic rats. Maximal force was substantially reduced in response to either KCl or 252 PE, and sensitivity to KCl was increased. Previous studies of arterial function in animals and in 253 humans with renal failure have yielded contradictory results, with both increased (2; 32) and 254 decreased (7; 11; 19; 27) alpha adrenergic sensitivity noted. The mechanisms underlying the 255 changes in smooth muscle function in uremia have not been investigated. The severe reduction 256 in maximum force in the absence of reduced smooth muscle mass indicates a significant 257 impairment in contractile capacity. The underlying mechanism is unknown but could involve 258 changes in vasoactive substances or the intracellular signaling cascades that regulate calcium 259 sensitivity in vascular smooth muscle (28). 260
Relaxation in response to acetylcholine, an endothelium-dependent dilator, was severely 261 impaired in the uremic rats in this study. Although relaxation to sodium nitroprusside, a direct 262 vasodilator, was also impaired, the reduction was not severe and could not entirely explain the 263 impaired response to acetylcholine. This impairment in endothelium-dependent relaxation has 264 been observed in prior studies, both in animals (10; 11) and in humans (21) ex vivo, and in 265 humans in vivo (9; 12; 20), but the impaired direct vasodilation has not previously been 266 Control (n = 6); □ Uremic, noncalcified (n = 8); ■ Uremic, calcified (n = 6). * p<0.05 compared 299 to control by two-way, repeated measures ANOVA followed by Bonferroni correction. Rats 300 were fed a 23 % protein and 1.06 % phosphorus diet. 301 302 
